Key details about the 2.5 mg starting dose include: Purpose Helps the body acclimate to tirzepatide Reduces the likelihood of digestive side effects Prepares patients for future dose increases Administration Injected once weekly A pen usually contains four doses for a one-month period Injection sites include the abdomen, thigh, or upper arm During this introductory stage, appetite may begin to change and the body gradually adapts, allowing clinicians to adjust doses safely based on individual response
Key Takeaway: The seven-day schedule is designed to match the medications half-life
Dosing schedules should be adjusted based on how you respond and what side effects you experience
and Boehringer Ingelheim Japan and speaker honoraria from Novo Nordisk Pharma Ltd., MSD K.K., Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., Sanofi K.K., Eli Lilly Japan K.K., Mitsubishi Tanabe Pharma Corporation, and Abbott Japan LLC